PT Soho Global Health Tbk (IDX:SOHO)
Indonesia · Delayed Price · Currency is IDR 1,195.00
-15.00 (-1.24%)
Sep 2, 2026, 2:26 PM WIB
PT Soho Global Health Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,972,612 | 10,779,187 | 10,057,938 | 8,197,755 | 7,290,121 | 7,076,164 | |
Revenue Growth | 6.06% | 7.17% | 22.69% | 12.45% | 3.02% | 14.80% |
Cost of Revenue | 8,980,764 | 8,997,395 | 8,538,685 | 6,907,699 | 5,971,583 | 5,529,262 |
Gross Profit | 1,991,848 | 1,781,792 | 1,519,253 | 1,290,056 | 1,318,538 | 1,546,902 |
Selling, General & Admin | 1,091,150 | 1,011,920 | 924,010 | 829,867 | 856,229 | 867,498 |
Research & Development | 29,924 | 25,463 | 23,033 | 21,060 | 20,927 | 21,964 |
Other Operating Expenses | 13,952 | 12,841 | 4,495 | -210 | -2,201 | 5,821 |
Operating Expenses | 1,135,026 | 1,050,224 | 951,538 | 850,717 | 874,955 | 895,283 |
Operating Income | 856,822 | 731,568 | 567,715 | 439,339 | 443,583 | 651,619 |
Interest Expense | -127 | -447 | -1,574 | -1,699 | -1,446 | -2,333 |
Interest & Investment Income | 23,482 | 21,203 | 18,659 | 26,425 | 13,945 | 23,552 |
Currency Exchange Gain (Loss) | -2,221 | -9,852 | 2,522 | -1,592 | -1,773 | -3,775 |
EBT Excluding Unusual Items | 877,956 | 742,472 | 587,322 | 462,473 | 454,309 | 669,063 |
Gain (Loss) on Sale of Investments | - | 29,093 | - | - | - | - |
Gain (Loss) on Sale of Assets | 1,018 | 299 | 716 | 923 | 1,328 | 22,094 |
Pretax Income | 878,974 | 771,864 | 588,038 | 463,396 | 455,637 | 691,157 |
Income Tax Expense | 196,091 | 171,543 | 125,387 | 92,055 | 98,622 | 140,066 |
Earnings From Continuing Operations | 682,883 | 600,321 | 462,651 | 371,341 | 357,015 | 551,091 |
Minority Interest in Earnings | - | - | - | - | -287 | -915 |
Net Income | 682,883 | 600,321 | 462,651 | 371,341 | 356,728 | 550,176 |
Net Income to Common | 682,883 | 600,321 | 462,651 | 371,341 | 356,728 | 550,176 |
Net Income Growth | 29.48% | 29.76% | 24.59% | 4.10% | -35.16% | 219.67% |
Shares Outstanding (Basic) | 12,692 | 12,692 | 12,692 | 12,692 | 12,692 | 12,692 |
Shares Outstanding (Diluted) | 12,692 | 12,692 | 12,692 | 12,692 | 12,692 | 12,692 |
Shares Change | - | - | - | - | - | 40.97% |
EPS (Basic) | 53.81 | 47.30 | 36.45 | 29.26 | 28.11 | 43.35 |
EPS (Diluted) | 53.81 | 47.30 | 36.45 | 29.26 | 28.11 | 43.35 |
EPS Growth | 29.48% | 29.76% | 24.59% | 4.10% | -35.16% | 126.76% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 904,901 | 852,515 | -165,035 | 172,378 | 335,514 | 585,719 |
Free Cash Flow Per Share | 71.30 | 67.17 | -13.00 | 13.58 | 26.44 | 46.15 |
Dividend Per Share | 39.500 | 72.600 | 24.000 | 31.700 | 23.600 | 19.700 |
Dividend Growth | -30.82% | 202.50% | -24.29% | 34.32% | 19.80% | -16.53% |
Gross Margin | 18.15% | 16.53% | 15.10% | 15.74% | 18.09% | 21.86% |
Operating Margin | 7.81% | 6.79% | 5.64% | 5.36% | 6.08% | 9.21% |
Profit Margin | 6.22% | 5.57% | 4.60% | 4.53% | 4.89% | 7.78% |
Free Cash Flow Margin | 8.25% | 7.91% | -1.64% | 2.10% | 4.60% | 8.28% |
EBITDA | 908,476 | 780,931 | 615,683 | 484,610 | 487,952 | 687,723 |
EBITDA Margin | 8.28% | 7.25% | 6.12% | 5.91% | 6.69% | 9.72% |
D&A For EBITDA | 51,654 | 49,363 | 47,968 | 45,271 | 44,369 | 36,104 |
EBIT | 856,822 | 731,568 | 567,715 | 439,339 | 443,583 | 651,619 |
EBIT Margin | 7.81% | 6.79% | 5.64% | 5.36% | 6.08% | 9.21% |
Effective Tax Rate | 22.31% | 22.23% | 21.32% | 19.86% | 21.64% | 20.27% |
Advertising Expenses | - | 335,733 | 290,215 | 252,097 | 302,663 | 311,028 |